Focus: AcuraStem is a Pasadena-based biotechnology company founded in 2008 specializing in patient-based therapeutics. The company operates at a limited scale with only 2 active job openings and minimal disclosed financial or pipeline data.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
AcuraStem is a high-risk, potentially high-reward opportunity best suited for scientists comfortable with uncertainty and early-stage risk in exchange for potential equity upside and hands-on influence.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AcuraStem
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AcuraStem's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo